Phase II Study of Cisplatin Plus Etoposide and Bevacizumab for Previously Untreated, Extensive-Stage Small-Cell Lung Cancer: Eastern Cooperative Oncology Group Study E3501

PURPOSE: To investigate the efficacy and safety of bevacizumab plus cisplatin and etoposide in patients with extensive-stage disease, small-cell lung cancer (ED-SCLC). PATIENTS AND METHODS: In this phase II trial, 63 patients were treated with bevacizumab 15 mg/kg plus cisplatin 60 mg/m(2) and etopo...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Horn, Leora, Dahlberg, Suzanne E., Sandler, Alan B., Dowlati, Afshin, Moore, Dennis F., Murren, John R., Schiller, Joan H.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Clinical Oncology 2009
Предметы:
Original Reports
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2793043/
https://ncbi.nlm.nih.gov/pubmed/19826110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.23.7545
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы